MintNeuro, a pioneer of scalable, low-power semiconductor technology for neural implant applications, and Motif Neurotech, a therapeutic brain-computer interface (BCI) company developing miniature ...

MintNeuro and Motif Neurotech today announced plans to accelerate the clinical availability of therapeutic brain-computer ...

CorTec GmbH today announced that the first participant in the University of Washington’s NIH-funded clinical trial of the Brain Interchange™ BCI system has successfully controlled a computer through ...

CorTec today announced a major milestone for the first participant in a trial for its Brain Interchange brain-computer ...

Michigan Medicine opened the Brain-Computer Interface Clinic — one of the first of its kind in the nation — on Dec. 16, 2025 to provide neurological assessments for patients with speech and motor ...

CorTec GmbH today announced that the U.S. Food and Drug Administration (FDA) has accepted the company into its Total Product Life Cycle Advisory Program (TAP), recognizing the Brain Interchange™ BCI ...

In an industry-first, the company Synchron and Mount Sinai Hospital in New York have enrolled their first human patient in a U.S. clinical trial called COMMAND to evaluate an endovascular ...

A research team has published details of a brain-computer interface that abandons the conventional approach of ...

Restoring both walking and sensation to patients with paraplegia is an ambitious goal—but a team of researchers from the Keck ...

California-based Cognixion is launching a clinical trial to allow paralyzed patients with speech disorders the ability to communicate without an invasive brain implant. Cognixion is one of several ...

QINGDAO, China, April 27, 2026 /PRNewswire/ -- Akso Health Group (NASDAQ: AHG) ("Akso Health" or the "Company") today announced the commencement of its next-generation, proprietary Brain-Computer ...

Months after announcing its first successful surgery, the Austin-based neurotechnology company aiming to rival Elon Musk’s Neuralink has received federal approval to begin its first long-term clinical ...